Literature DB >> 6323075

Treatment of chronic renal failure with dietary fiber.

D S Rampton, S L Cohen, V D Crammond, J Gibbons, M F Lilburn, J Y Rabet, A J Vince, J D Wager, O M Wrong.   

Abstract

We have tested the hypothesis that dietary fiber, by inhibiting colonic bacterial ammonia generation and increasing fecal nitrogen excretion, might decrease hepatic urea synthesis and thereby reduce plasma urea in patients with chronic renal failure. Six and 8 week courses of two different hemicelluloses, arabinogalactan and ispaghula, reduced mean plasma urea in uremic subjects by 11% and 19% respectively. Ispaghula also reduced the rate of rise of plasma creatinine to zero and, in one formal balance study, increased fecal nitrogen excretion by 39%. Experiments in vitro showed that ispaghula depressed anaerobic fecal bacterial net ammonia generation by 30%, and adsorbed neither urea nor ammonia. The reduction in plasma urea caused by dietary fiber is likely to be due to inhibition of colonic bacterial production of ammonia; such therapy could conceivably alleviate some of the symptoms of uremia and postpone dialysis in patients with endstage renal disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323075

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  15 in total

1.  Dietary fiber in conservative management of chronic renal failure.

Authors:  Donna Zimmaro Bliss
Journal:  Pediatr Nephrol       Date:  2004-08-04       Impact factor: 3.714

Review 2.  Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials.

Authors:  L Chiavaroli; A Mirrahimi; J L Sievenpiper; D J A Jenkins; P B Darling
Journal:  Eur J Clin Nutr       Date:  2014-11-12       Impact factor: 4.016

3.  Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

Authors:  Tammy L Sirich; Natalie S Plummer; Christopher D Gardner; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 8.237

4.  Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.

Authors:  Younis A Salmean; Mark S Segal; Sergiu P Palii; Wendy J Dahl
Journal:  J Ren Nutr       Date:  2014-11-05       Impact factor: 3.655

5.  Effects of amylose and wheat bran on the levels of blood serum urea nitrogen (BUN), other blood parameters, growth and fecal characteristics in rats.

Authors:  R Mongeau; G Sarwar; R Brassard; H G Botting
Journal:  Plant Foods Hum Nutr       Date:  1995-09       Impact factor: 3.921

Review 6.  Nutritional management of children with chronic renal failure. Summary of the task force on nutritional management of children with chronic renal failure.

Authors:  S Hellerstein; M A Holliday; W E Grupe; R N Fine; R S Fennell; R W Chesney; J C Chan
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

7.  Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats.

Authors:  Dorothy A Kieffer; Brian D Piccolo; Nosratola D Vaziri; Shuman Liu; Wei L Lau; Mahyar Khazaeli; Sohrab Nazertehrani; Mary E Moore; Maria L Marco; Roy J Martin; Sean H Adams
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

8.  The Efficiency of Barley (Hordeum vulgare) Bran in Ameliorating Blood and Treating Fatty Heart and Liver of Male Rats.

Authors:  Khalid O Abulnaja; Haddad A El Rabey
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-17       Impact factor: 2.629

9.  Efficiency of barley bran and oat bran in ameliorating blood lipid profile and the adverse histological changes in hypercholesterolemic male rats.

Authors:  Haddad A El Rabey; Madeha N Al-Seeni; Hanan M Amer
Journal:  Biomed Res Int       Date:  2013-08-01       Impact factor: 3.411

10.  Foods with added fiber improve stool frequency in individuals with chronic kidney disease with no impact on appetite or overall quality of life.

Authors:  Younis A Salmean; Gordon A Zello; Wendy J Dahl
Journal:  BMC Res Notes       Date:  2013-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.